CTOs on the Move

MedeAnalytics

www.medeanalytics.com

 
MedeAnalytics provides evidence-based insights to solve a real problem that plagues health care – how to use the immense amount of patient data collected along the care continuum to deliver cost – effective care and promote a healthier population. The platform delivers intelligence that helps healthcare organizations detect their greatest areas of risk and identify opportunities to improve their financial health. It empowers providers and health plans to collaborate and use data to strengthen their operations and improve the quality of care. MedeAnalytics` cloud-based tools have been used to analyze more than 21 billion patient encounters in the United States ...
  • Number of Employees: 100-250
  • Annual Revenue: $50-100 Million
  • www.medeanalytics.com
  • 501 W President George Bush Highway Suite 250
    Richardson, TX USA 75080
  • Phone: 469.916.3300

Executives

Name Title Contact Details
Sree Ghantasala
 Chief Technology Officer Profile
Atahan Bozdag
 Director, Information Security and Risk Profile
Scott Checkoway
 Chief Information Officer Profile
Cindi Carter
 Chief Security Officer Profile
Tyler Downs
 Chief Technology Officer Profile

Similar Companies

Zotec Partners

Zotec Partners is an industry leading provider of specialized medical billing and practice management services for the hospital-based specialty market. The company is committed to the continual pursuit of excellence in the physician revenue cycle management industry by delivering effective solutions through personalized service and measurable client results. Zotec Partners` proprietary processes and technology manage in excess of 70 million medical encounters across all 50 states.

MedHunters

MedHunters is a Toronto, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Telesta Therapeutics

Telesta Therapeutics is a biopharmaceutical company focused on the development, manufacturing and commercialization of transformative human therapeutics. Our main focus is on novel medicines that address major unmet medical needs, particularly in oncology. Our anchor product, MCNA, has completed a Phase III pivotal study in patients with non-muscle invasive bladder cancer that have failed the first line therapy, bacillus Calmette-Guérin (BCG). Telesta submitted a Biologics Licensing Application (BLA) for MCNA with the U.S. FDA on June 29, 2015 and is seeking, upon marketing approval in the U.S., to make MCNA available for patients and their physicians. Our ultimate goal is to transform the treatment landscape and prolong and improve the lives of those affected by bladder cancer, one of the most common types of cancers today.

C S H Associates Inc

C S H Associates Inc is a Burlington, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Blue River PetCare

we can help Selling your Veterinary clinic with the help of Blue River Pet Care. Receive a Veterinary Practice Valuation. We acquire veterinary hospitals that provide high-quality clinical care and leading rate customer service.